Teenagers Are Taking New Weight-Loss Drugs, but the Science Is Far from Settled
Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known about their long-term effects
The Truth About Weight Loss Drugs
Here's what to know about weight loss drugs such as Wegovy and Zepbound. CR helps you decide whether semaglutide or tirzepatide is right for you.
Weight-loss drugs didn't curb health costs within two years
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims shared with Reuters.
Ozempic and other weight loss drugs aren't lowering health care costs yet
GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according to a new analysis of U.S. health insurance claims.
Weight-loss drugs may be no obesity silver bullet
Sir Keir Starmer and his health secretary have been lauding the potential of the new generation of weight-loss drugs. Given as regular injections, the treatments – Wegovy and Mounjaro – mimic a hormone that makes people less hungry.
Opinion
Stop the games. Make NC healthier by expanding weight-loss drug coverage | Opinion
Despite the benefits of such medicines, like Wegovy, Saxenda and Zepbound, many people who could most benefit from them can’t get them. | Opinion
US Medicaid Programs Say Cost a Key Factor for Weight-Loss Drug Coverage, Survey Finds
The survey of the 50 states and the District of Columbia found that just 12 Medicaid programs covered the drugs to treat obesity as of July 2024 with some limits on use. Half of the states without coverage said they are considering adding them or evaluating their coverage,
Study finds high costs, few benefits associated with GLP-1 weight loss drugs
A new study from a pharmacy benefit manager is casting doubt on the benefits of GLP-1 drugs used for weight loss, finding they are associated with a high cost of care with little benefit beyond dropping pounds.
More state Medicaid programs consider covering GLP-1 drugs
While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs for obesity. Currently, just 13 state Medicaid programs cover GLP-1s for obesity.
New anti-obesity drug shows promise in preventing heart failure related to type 2 diabetes
A University of Alberta pharmacology researcher has discovered that a new experimental anti-obesity drug improves diastolic ...
The Economist1d
It’s not just obesity. Drugs like Ozempic will change the world
First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to ...
STAT1h
In the era of GLP-1 drugs, demand for bariatric surgery plunges
The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from ...
Bariatric surgery decline tied to rise in GLP-1 drugs to treat obesity
A new study by researchers at Brigham and Women's Hospital in collaboration with researchers at Harvard T.H. Chan School of ...
Adolescents treated for obesity with GLP-1 drugs had lower risk of suicidal thoughts, study finds
“We know that generally, with and without obesity, mental health and suicidality is ... who has done similar work analyzing ...
The ‘Peak Obesity’ Illusion
America’s obesity rate looks to be plateauing—again.
Boosting Access to Weight-Loss Drugs Could Save Thousands of Lives
The lives of Americans could be dramatically improved, and in thousands of cases even saved, by increasing access to ...